China’s medicines regulator has granted the nod for the treatment of people with chronic inflammatory demyelinating ...

Analyst Terence Flynn from Morgan Stanley maintained a Buy rating on Intellia Therapeutics (NTLA – Research Report) and keeping the price ...

Argenx (ARGX) stock upgraded at Wolfe Research citing dominance in myasthenia gravis market and profitability outlook. Read ...

慢性炎性脱髓鞘性多发性神经根神经病（CIDP）是一种罕见的由免疫介导的脱髓鞘性周围神经病1。CIDP患者会经历一系列的行动和感觉问题，包括从坐姿站起来困难、疼痛和疲劳、经常绊倒或摔倒。随着疾病进展，许多患者需依赖轮椅且无法工作，对患者造成严重的疾病负 ...

Zai Lab and argenx have announced receipt of approval from the National Medical Products Administration (NMPA) of China for ...

In a report released today, Tyler Van Buren from TD Cowen maintained a Buy rating on BridgeBio Pharma (BBIO – Research Report). The ...

Wolfe has downgraded Alnylam Pharmaceuticals (NASDAQ:ALNY) to underperform from peer perform as it issues a contrarian view ...

BioSpace takes a look at the headlines across a heavy earnings week for biotechs, checking in on Allogene, Rapport and more.

Nipocalimab is a fully human monoclonal antibody that blocks FcRn and decreases levels of circulating IgG antibodies.

Spring House, Massachusetts Wednesday, November 13, 2024, 14:00 Hrs [IST] ...